Rates of hospitalization among patients with deep vein thrombosis before and after the introduction of rivaroxaban
作者： Geno J. Merli , Judd E. Hollander , Patrick Lefebvre , François Laliberté , Monika K. Raut
DOI: 10.1080/21548331.2015.1021659
关键词:
摘要: Background. Compared to warfarin, the non-vitamin K antagonist oral anticoagulant rivaroxaban may have advantages in treating patients with venous thromboembolism, because injectable bridging thera...
informahealthcare.com
researchgate.net 参考文章(19)
Michele G. Beckman, W. Craig Hooper, Sara E. Critchley, Thomas L. Ortel, Venous Thromboembolism: A Public Health Concern American Journal of Preventive Medicine. ,vol. 38, ,(2010) , 10.1016/J.AMEPRE.2009.12.017
Oral rivaroxaban for symptomatic venous thromboembolism. The New England Journal of Medicine. ,vol. 364, pp. 1178- 1178 ,(2011) , 10.1056/NEJMC1100734
Richard Othieno, Emmanuel Okpo, Rachel Forster, Home versus in-patient treatment for deep vein thrombosis. Cochrane Database of Systematic Reviews. ,vol. 1, pp. 0- 0 ,(2007) , 10.1002/14651858.CD003076.PUB3
Giancarlo Agnelli, Cecilia Becattini, Laura Franco, New oral anticoagulants for the treatment of venous thromboembolism Best Practice & Research Clinical Haematology. ,vol. 26, pp. 151- 161 ,(2013) , 10.1016/J.BEHA.2013.07.005
Frederick A. Spencer, Cathy Emery, Samuel W. Joffe, Luigi Pacifico, Darleen Lessard, George Reed, Joel M. Gore, Robert J. Goldberg, Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study Journal of Thrombosis and Thrombolysis. ,vol. 28, pp. 401- 409 ,(2009) , 10.1007/S11239-009-0378-3
Francisco Lozano, Javier Trujillo-Santos, Manuel Barrón, Pedro Gallego, Dimitrios Babalis, Mafalda Santos, Conxita Falgá, Manuel Monreal, Riete Investigators, None, Home versus in-hospital treatment of outpatients with acute deep venous thrombosis of the lower limbs Journal of Vascular Surgery. ,vol. 59, pp. 1362- 1367 ,(2014) , 10.1016/J.JVS.2013.11.091
P. Prandoni, M. Carta, A. Cogo, A. Ruol, M. Vigo, D. Casara, A.W.A. Lensing, H.R. Büller, J.W. ten Cate, Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis The Lancet. ,vol. 339, pp. 441- 445 ,(1992) , 10.1016/0140-6736(92)91054-C
Patricia A. Cowper, Wenqin Pan, Kevin Anstrom, Judith Stafford, Renato Lopes, Linda Davidson-Ray, Lars Wallentin, Hemant Phatak, Jack Ansell, Paul Dorian, Steen Husted, John McMurray, P. Gabriel Steg, John Alexander, Christopher Granger, Daniel Mark, APIXABAN REDUCES HOSPITALIZATION IN PATIENTS WITH ATRIAL FIBRILLATION: AN ANALYSIS OF THE EFFECT OF APIXABAN THERAPY ON RESOURCE USE IN THE APIXABAN FOR REDUCTION IN STROKE AND OTHER THROMBOEMBOLIC EVENTS IN ATRIAL FIBRILLATION TRIAL Journal of the American College of Cardiology. ,vol. 61, ,(2013) , 10.1016/S0735-1097(13)61576-4
S. B. Deitelzweig, B. H. Johnson, J. Lin, K. L. Schulman, Prevalence of clinical venous thromboembolism in the USA: current trends and future projections. American Journal of Hematology. ,vol. 86, pp. 217- 220 ,(2011) , 10.1002/AJH.21917
François Laliberté, Dominic Pilon, Monika K. Raut, Winnie W. Nelson, William H. Olson, Guillaume Germain, Jeff R. Schein, Patrick Lefebvre, Hospital length of stay: is rivaroxaban associated with shorter inpatient stay compared to warfarin among patients with non-valvular atrial fibrillation? Current Medical Research and Opinion. ,vol. 30, pp. 645- 653 ,(2014) , 10.1185/03007995.2013.867843